K2 Principal Fund’s Organogenesis Holdings ORGO Stock Holding History

K2 Principal Fund’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-89,191	Closed	-$429K	–	295
2019 Q4	$429K	Buy	+89,191	New	+$565K	0.04%	247
2018 Q4	–	Sell	-616,020	Closed	-$6.24M	–	333
2018 Q3	$6.24M	Buy	616,020 +296,199	+93%	+$2.99M	0.6%	50
2018 Q2	$3.2M	Sell	319,821 -121,088	-27%	-$1.21M	0.25%	118
2018 Q1	$4.37M	Sell	440,909 -25	-0%	-$249	0.25%	106
2017 Q4	$4.37M	Buy	440,934 +95,000	+27%	+$943K	0.32%	85
2017 Q3	$3.46M	Sell	345,934 -4,066	-1%	-$40.4K	0.23%	98
2017 Q2	$3.45M	Hold	350,000	–	–	0.23%	107
2017 Q1	$3.45M	Buy	+350,000	New	+$3.46M	0.29%	93

Other funds holding ORGO

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

K2 Principal Fund's ORGO Position: Q1 2020 in Review

K2 Principal Fund sold out of Organogenesis Holdings (ORGO) in Q1 2020, closing a stake of 89,191 shares — an estimated $429K sold.

K2 Principal Fund first reported a position in ORGO in Q1 2017 and held it in 8 quarters. The position peaked at $6.24M in Q3 2018. 52 funds tracked by Wall St. Rank hold ORGO as of Q1 2020.

K2 Principal Fund reported no remaining Organogenesis Holdings position as of Q1 2020 after selling out during the quarter.
K2 Principal Fund sold 89,191 Organogenesis Holdings shares in Q1 2020, an estimated $429K.
K2 Principal Fund first reported a position in Organogenesis Holdings in Q1 2017 and held it in 8 quarters.
K2 Principal Fund's Organogenesis Holdings position peaked at $6.24M in Q3 2018.
52 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2020.

Based on K2 Principal Fund's 13F filing for Q1 2020, filed 15 May 2020.